当前位置： SCI文献检索 > ANNALS OF HEMATOLOGY期刊下所有文献 > Granulocyte-macrophage colony-stimulating factor and interleukin-3 in combination: a potent and consistent myelodysplastic syndrome bone marrow stimulant in vitro.

Granulocyte-macrophage colony-stimulating factor and interleukin-3 in combination: a potent and consistent myelodysplastic syndrome bone marrow stimulant in vitro.

Abstract：

:In an effort to overcome bone marrow failure in myelodysplastic syndrome (MDS), we have investigated recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) in phase I-II clinical trials. Although these agents partially increased peripheral blood granulocyte counts, their effect on other hematopoietic lineages was generally sporadic. Since in vitro analysis and in vivo studies in primates indicate that GM-CSF and IL-3 synergistically enhance hematopoietic stem cell proliferation, we evaluated their combined effect on marrow progenitors obtained from ten MDS patients. When used singly, each growth factor stimulated replication of granulocyte-macrophage (CFU-GM) and erythroid (BFU-E) colony-forming cells in a dose-dependent fashion. When colony-stimulating activity was compared at concentrations that maximally amplified individual MDS patients' colony numbers, IL-3 was a more potent stimulant in some patients and GM-CSF in others. When used in combination, IL-3 plus GM-CSF was more effective than each growth factor by itself in five of six patients. Our data indicate that the MDS hematopoietic progenitor stimulatory effect of these growth factors varies from patient to patient. However, the combination of GM-CSF and IL-3 appears to be more potent than the individual molecules in the majority of patients.

journal_name

Ann Hematol

journal_title

Annals of hematology

authors

Estrov Z,Kurzrock R,Talpaz M,Blake M,Gutterman JU

doi

10.1007/BF01709650

subject

Has Abstract

pub_date

1991-12-01 00:00:00

pages

297-301

issue

6

eissn

0939-5555

issn

1432-0584

journal_volume

63

pub_type

杂志文章

相关文献

ANNALS OF HEMATOLOGY文献大全
  • Genetic polymorphisms of HbE/beta thalassemia related to clinical presentation: implications for clinical diversity.

    abstract：:HbE/Beta thalassemia (HbE/β-thalassemia) is one of the common genetic disorders in South East Asia. It is heterogeneous in its clinical presentation and molecular defects. There are genetic modifiers which have been reported to influence the disease severity of this disorder. The aim of this study was to determine the...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-020-03927-5

    authors： Azman NF,Abdullah WZ,Hanafi S,Diana R,Bahar R,Johan MF,Zilfalil BA,Hassan R

    更新日期：2020-04-01 00:00:00

  • Pruritus in primary myelofibrosis: management options in the era of JAK inhibitors.

    abstract：:Primary myelofibrosis (PMF)-associated pruritus is often severe and requires treatment. Fifty-one patients with bone marrow-proven PMF with associated pruritus were identified from a primary cohort of patients with PMF (n = 566) seen at our institution. We conducted a retrospective review of the clinical characteristi...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-016-2674-2

    authors： Vaa BE,Tefferi A,Gangat N,Pardanani A,Lasho TL,Finke CM,Wolanskyj AP

    更新日期：2016-06-01 00:00:00

  • Thrombotic thrombocytopenic purpura in a patient with sickle cell crisis.

    abstract：:The combination of sickle cell disease crisis and thrombotic thrombocytopenic purpura has been described only a few times. Here we present the case of a patient with a hemolytic crisis due to sickle cell disease complicated by thrombotic thrombocytopenic purpura. We also review the cases previously reported and compar...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s002770050558

    authors： Bolaños-Meade J,Keung YK,López-Arvizu C,Florendo R,Cobos E

    更新日期：1999-12-01 00:00:00

  • Erythropoietin production: evidence for multiple oxygen sensing pathways.

    abstract：:The production of erythropoietin (Epo), the glycoprotein hormone which controls red blood cell formation, is regulated by feedback mechanisms sensing tissue oxygenation. The mechanism of the putative oxygen sensor has yet to be elucidated. There is evidence that at least two pathways participate in hypoxia signal tran...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s002770050514

    authors： Daghman NA,Elder GE,Savage GA,Winter PC,Maxwell AP,Lappin TR

    更新日期：1999-06-01 00:00:00

  • The effects of air quality on haematological and clinical parameters in children with sickle cell anaemia.

    abstract：:Sickle cell anaemia (SCA; HbSS) is characterised by its clinical variability, which is only partly explained by known genetic factors. Environmental factors are known to contribute to acute problems but their importance in chronic complications has not been analysed. We have studied 93 children with SCA in a single in...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-008-0598-1

    authors： Mittal H,Roberts L,Fuller GW,O'Driscoll S,Dick MC,Height SE,Thein SL,Rees DC

    更新日期：2009-06-01 00:00:00

  • Meis1 is critical to the maintenance of human acute myeloid leukemia cells independent of MLL rearrangements.

    abstract：:Although the outcome of patients with acute myeloid leukemia (AML) has improved by optimized chemotherapy regimens and bone marrow transplantation, leukemia relapse remains one of the most challenging problems during therapy. Sustained existence of AML blasts is a fundamental determinant for the development of leukemi...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-016-2913-6

    authors： Liu J,Qin YZ,Yang S,Wang Y,Chang YJ,Zhao T,Jiang Q,Huang XJ

    更新日期：2017-04-01 00:00:00

  • B cell-activating factor: its clinical significance in multiple myeloma patients.

    abstract：:B cell-activating factor (BAFF) is a cytokine that plays a major role in the maintenance of normal B-cell development and homeostasis. It has been suggested that in multiple myeloma (MM) it might have regulatory effects on the proliferation and viability of malignant plasma cells. The aim of this study was to evaluate...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-012-1470-x

    authors： Fragioudaki M,Boula A,Tsirakis G,Psarakis F,Spanoudakis M,Papadakis IS,Pappa CA,Alexandrakis MG

    更新日期：2012-09-01 00:00:00

  • Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era.

    abstract：:Several revisions of International Prognostic Index (IPI) have been proposed for patients with diffuse large B-cell lymphoma (DLBCL) after the introduction of rituximab. Expanding evidence suggests that baseline absolute lymphocyte count (ALC) is also an independent factor for outcome prediction. We investigated the o...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-013-1807-0

    authors： Huang YC,Liu CY,Lu HJ,Liu HT,Hung MH,Hong YC,Hsiao LT,Gau JP,Liu JH,Hsu HC,Chiou TJ,Chen PM,Tzeng CH,Yu YB

    更新日期：2013-11-01 00:00:00

  • Blood B, T, CD4+ and CD8+ lymphocytes in female Wistar rats.

    abstract：:We have established reference values of peripheral blood lymphocyte subsets in healthy female Wistar rats under highly standardized conditions. Using monoclonal antibodies and flow cytometry, T lymphocytes (OX19+), B lymphocytes (OX6+ and anti-Ig+), T-helper/inducer (W3/25+), and T-suppressor/cytotoxic subsets (OX8+) ...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/BF01701732

    authors： Franch A,Castellote C,Pelegrí C,Tolosa E,Castell M

    更新日期：1993-09-01 00:00:00

  • Measuring holotranscobalamin II, an early indicator of negative vitamin B12 balance, by radioimmunoassay in patients with ischemic cerebrovascular disease.

    abstract：:Circulating homocysteine is a risk factor of cardiovascular and cerebrovascular events. Hyperhomocysteinemia may be an early indicator for vitamin B12 disorders because cobalamin is a cofactor in the remethylation process of homocysteine. Serum holotranscobalamin (holoTC II) becomes decreased before the development of...

    journal_title：Annals of hematology

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00277-007-0406-3

    authors： Serefhanoglu S,Aydogdu I,Kekilli E,Ilhan A,Kuku I

    更新日期：2008-05-01 00:00:00

  • Notch1 signaling is irresponsible to the anti-leukemic effect of HDACis in B-ALL Nalm-6 cells.

    abstract：:B cell acute lymphoblastic leukemia (B-ALL) is an aggressive hematologic malignancy with limited treatment strategies. Histone deacetylases inhibitors (HDACis) are promising novel tools for cancer therapy, whose anti-tumor effects and the underlying mechanisms on B-ALL remain to be elucidated. Recently, Notch1 signali...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-012-1561-8

    authors： Shao N,Ma D,Wang J,Lu T,Guo Y,Ji C

    更新日期：2013-01-01 00:00:00

  • Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia.

    abstract：:The microRNA/miR deregulation in BCR-ABL-negative myelodysplastic-myeloproliferative neoplasms (MDS/MPN) is not known. Myelopoiesis-associated miR-10a, miR-17-5p, miR-155, miR-223 and miR-424 were analysed by real-time polymerase chain reaction (PCR) in bone marrow cells of atypical chronic myeloid leukaemia (aCML, n ...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-010-1072-4

    authors： Hussein K,Büsche G,Muth M,Göhring G,Kreipe H,Bock O

    更新日期：2011-03-01 00:00:00

  • Primary acquired sideroblastic anemia, thrombocytosis, and trisomy 8.

    abstract：:Myelodysplastic syndromes are usually associated with pancytopenia. Disorders involving deletion of the long arm of chromosome 5 (5q-syndrome) and, rarely, patients with karyotypic abnormalities involving chromosome 3 associated with abnormal thrombopoiesis may have a normal or even raised platelet count. Other cytoge...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s002770050283

    authors： Patel K,Kelsey P

    更新日期：1997-04-01 00:00:00

  • DNA fragmentation as a consequence of cell cycle traverse in doxorubicin- and idarubicin-treated human lymphoma cells.

    abstract：:We have studied some of the factors involved in the cytotoxic actions of the anticancer anthracycline antibiotics doxorubicin (DOX) and idarubicin (IDA) towards human B-cell lymphoma cells in vitro. IDA was found to accumulate within cells to a greater degree than the related drug DOX for both short (1 h) and long-ter...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/BF01757348

    authors： Smith PJ,Rackstraw C,Cotter F

    更新日期：1994-01-01 00:00:00

  • Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL)-a single region experience on consecutive patients.

    abstract：:Alemtuzumab, a humanized anti-CD52 monoclonal antibody, is used in patients with refractory chronic lymphocytic leukaemia (CLL). We report results in health care with alemtuzumab on consecutive, advanced-stage patients from a well-defined geographical region. Records from 1,301 patients (Stockholm-Cancer-Registry 1991...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-014-2105-1

    authors： Eketorp Sylvan S,Lundin J,Ipek M,Palma M,Karlsson C,Hansson L

    更新日期：2014-10-01 00:00:00

  • sIL2R ratio as early marker for response in hairy cell leukemia and the prognostic relevance of IL28B genotype to interferon-α therapy.

    abstract：:Interferon-α (IFNα) was the first effective drug therapy for hairy cell leukemia (HCL). Nowadays, it is used as an alternative treatment in selected patients. Due to unlimited treatment time, monitoring and early prediction of response are important. Moreover, IFNα is used in the therapy of chronic hepatitis C, where ...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-017-2943-8

    authors： Jud S,Goede JS,Senn O,Spanaus K,Manz MG,Benz R

    更新日期：2017-05-01 00:00:00

  • Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization.

    abstract：:Fanconi anemia (FA) is a DNA repair disorder resulting from mutations in genes encoding for FA DNA repair complex components and is characterized by variable congenital abnormalities, bone marrow failure (BMF), and high incidences of malignancies. FA mosaicism arises from reversion or other compensatory mutations in h...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-020-03954-2

    authors： Nicoletti E,Rao G,Bueren JA,Río P,Navarro S,Surrallés J,Choi G,Schwartz JD

    更新日期：2020-05-01 00:00:00

  • Clinical characteristics and prognosis of immunoglobulin D myeloma in the novel agent era.

    abstract：:Immunoglobulin D (IgD) myeloma is a rare subtype that used to lead to a poor outcome. To investigate the current clinical features, cytogenetic changes and survival of patients with IgD myeloma under novel treatments, we analysed 47 patients with IgD myeloma, 31 men and 16 women, with a median age of 54.5 years. We fo...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-018-3582-4

    authors： Chen L,Fan F,Deng J,Xu J,Xu A,Sun C,Hu Y

    更新日期：2019-04-01 00:00:00

  • Rituximab therapy for hairy cell leukemia: a retrospective study of 41 cases.

    abstract：:The purine analogs (PAs) cladribine and pentostatin have transformed the prognosis of hairy cell leukemia (HCL). However, some patients still relapse after PAs, or fail to reach an optimal response, and new agents are needed to further improve treatment outcome. We retrospectively studied 41 HCL patients from 10 cente...

    journal_title：Annals of hematology

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s00277-014-2175-0

    authors： Leclerc M,Suarez F,Noël MP,Vekhoff A,Troussard X,Claisse JF,Thieblemont C,Maloisel F,Beguin Y,Tamburini J,Barbe C,Delmer A

    更新日期：2015-01-01 00:00:00

  • PD-L1, LAG3, and HLA-DR are increasingly expressed during smoldering myeloma progression.

    abstract：:Symptomatic multiple myeloma (MM) is a plasma cell neoplasm that represents the final stage of a continuum of clinical conditions that start from monoclonal gammopathy of unknown significance (MGUS), then transits in the more advance, but still asymptomatic, smoldering MM (SMM), with a final evolution in symptomatic M...

    journal_title：Annals of hematology

    pub_type： 临床试验,杂志文章

    doi：10.1007/s00277-019-03648-4

    authors： Mussetti A,Pellegrinelli A,Cieri N,Garzone G,Dominoni F,Cabras A,Montefusco V

    更新日期：2019-07-01 00:00:00

  • Subtyping of human T-lymphotropic virus type I by amplification of long terminal repeat sequences and restriction fragment length polymorphism analysis in carriers with multiple transfusions.

    abstract：:Five major subtypes of human T-lymphotropic virus type I (HTLV-I) have been proposed: cosmopolitan, Japanese, West African, Central African, and Melanesian. Based on nucleotide variations specific to particular subtypes, it was possible to genotype HTLV-I rapidly by restriction fragment length polymorphism (RFLP) stud...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s002770050213

    authors： Lin MT,Yang YC,Chen PJ,Tang JI,Tseng LH,Wang CW,Chen YC

    更新日期：1996-09-01 00:00:00

  • Thrombotic thrombocytopenic purpura without any evidence of thrombotic lesions at autopsy.

    abstract：:Diagnosis of thrombotic thrombocytopenic purpura (TTP) is usually based upon the clinical features, and does not always involve histopathological evidence. We recently had experience with a patient who developed the five signs characteristic for TTP. He had been treated for liver cirrhosis associated with chronic hepa...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s002770100323

    authors： Hori A,Kami M,Hamaki T,Yamamoto T,Mori M,Miyakoshi S,Takeuchi K

    更新日期：2001-08-01 00:00:00

  • Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.

    abstract：:The benefits of intensive post-remission chemotherapy have not been verified in elderly patients with acute myeloid leukemia (AML). To reduce fatal complications caused by intensive post-remission therapy, we performed a prospective phase II multicenter trial of standard induction chemotherapy ('7+3' of cytarabine plu...

    journal_title：Annals of hematology

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s00277-006-0110-8

    authors： Lee JH,Choi SJ,Lee JH,Park JH,Kim H,Joo YD,Lee WS,Zang DY,Kim HJ,Lee KH,Cooperative Study Group A for Hematology.

    更新日期：2006-06-01 00:00:00

  • Second line azacitidine for elderly or infirmed patients with acute myeloid leukemia (AML) not eligible for allogeneic hematopoietic cell transplantation-a retrospective national multicenter study.

    abstract：:Elderly and infirm patients with acute myeloid leukemia (AML) with either induction refractory or relapse disease may benefit from treatment with azacitidine. We retrospectively reviewed the data from five tertiary centers in Israel, treated between 2009 and 2015. Thirty-four patients (median age 74 years) were identi...

    journal_title：Annals of hematology

    pub_type： 杂志文章,多中心研究

    doi：10.1007/s00277-016-2914-5

    authors： Ram R,Gatt M,Merkel D,Helman I,Inbar T,Nagler A,Avivi I,Ofran Y

    更新日期：2017-04-01 00:00:00

  • Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B.

    abstract：:A case of disseminated infection with Fusarium oxysporum following chemotherapy of acute myelogenous leukemia is reported. Antifungal treatment was successful with a 13-day course of oral terbinafine 250 mg t.i.d. in combination with amphotericin B deoxycholate 1.0-1.5 mg/kg qd and subsequently intravenous liposomal a...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-003-0795-x

    authors： Rothe A,Seibold M,Hoppe T,Seifert H,Engert A,Caspar C,Karthaus M,Fätkenheuer G,Bethe U,Tintelnot K,Cornely OA

    更新日期：2004-06-01 00:00:00

  • Evaluation of a new protein-C concentrate and comparison of protein-C assays in a child with congenital protein-C deficiency.

    abstract：:We investigated a new protein-C (PC) concentrate in a child with a type-II homozygous deficiency, concerning tolerance and safety. By means of various functional and antigen assays the in vivo recovery and the half-life were determined. In order to compare the results we reduced the measured values to the average half...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/BF01697402

    authors： Auberger K

    更新日期：1992-03-01 00:00:00

  • Maintenance therapy in childhood acute myeloid leukemia.

    abstract：PURPOSE:To determine whether, after very intensive induction and consolidation therapy in childhood AML, further maintenance therapy (MT) confers any advantage. PATIENTS AND METHODS:Three hundred-nine children with previously untreated AML were registered in the LAME 89/91 protocol. This three-cycle intensive regimen ...

    journal_title：Annals of hematology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1007/s00277-004-0850-2

    authors： Perel Y,Auvrignon A,Leblanc T,Michel G,Vannier JP,Dalle JH,Gandemer V,Schmitt C,Mèchinaud F,Lamagnere JP,Piguet Ch,Couillaud G,Pautard B,Baruchel A,Leverger G,Group LAME.,French Society of Pediatric Hematology and Immunol

    更新日期：2004-01-01 00:00:00

  • High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study.

    abstract：:A prospective randomized phase III study was performed to evaluate whether intensified cytarabine would induce a higher response rate and longer event-free interval as compared to low-dose cytarabine in chronic myeloid leukemia (CML). One hundred and eighteen patients with CML in early chronic phase entered the study....

    journal_title：Annals of hematology

    pub_type： 杂志文章,随机对照试验

    doi：10.1007/s00277-006-0186-1

    authors： Deenik W,van der Holt B,Verhoef GE,Schattenberg AV,Verdonck LF,Daenen SM,Zachée P,Westveer PH,Smit WM,Wittebol S,Schouten HC,Löwenberg B,Ossenkoppele GJ,Cornelissen JJ

    更新日期：2007-02-01 00:00:00

  • Cytomegalovirus infection in patients with haematological diseases and after autologous stem cell transplantation as consolidation: a single-centre study.

    abstract：:Because of the widespread use of immunosuppressive drugs, CMV infection is one of the most important causes of morbidity and mortality in patients with haematological malignancies worldwide. The aim of the study was to retrospectively analyse the epidemiology of CMV infection in haematological patients. Between 2008 a...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-016-2831-7

    authors： Piukovics K,Terhes G,Gurbity-Pálfi T,Bereczki Á,Rárosi F,Deák J,Borbényi Z,Urbán E

    更新日期：2017-01-01 00:00:00

  • Characterization of deletional and non-deletional alpha globin variants in a large cohort from Spain between 2009 and 2014.

    abstract：:The hemoglobinopathies are a group of disorders passed down through families (inherited) in which there is abnormal production or structure of the hemoglobin molecule. They are among the most common inherited diseases around the world. Those that produce abnormal hemoglobin are called structural hemoglobinopathies whi...

    journal_title：Annals of hematology

    pub_type： 杂志文章

    doi：10.1007/s00277-019-03696-w

    authors： de la Fuente-Gonzalo F,Nieto JM,Villegas A,González FA,Martínez R,Ropero P

    更新日期：2019-07-01 00:00:00